# GemGem Therapeutics Co.

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/gemgem-therapeutics-co

- Industry: Software
- Headquarters: Seoul, South Korea
- Website: www.gemgem.me/
- Total disclosed funding: $0.2M
- Latest round: Seed (Dec 29, 2023)
- Investors on record: 2

## About

Founded in 2023 and based in Seoul, South Korea, Jam Jam Therapeutics Co., Ltd. operates as a developer of augmented reality games for special education and rehabilitation. In December 2023, Jam Jam Therapeutics Co., Ltd. raised KRW 300 million in seed funding led by Korea Investment Accelerator, including Digital Healthcare Partners. As of 2023, the company is led by its CEO, Jeong-eun Kim. In June 2024, Gemgem Therapeutics raised KRW 200 million in seed funding from new investor Korea Social Investment.

The company offers JamJami AR, which is a rehabilitation solution designed primarily for children facing developmental delays. The firm’s product harnesses machine learning-driven motion recognition technology that eliminates the necessity for specialized equipment, enabling children to engage in rehabilitation exercises through games. Jam Jam’s feature captivates children who typically struggle with or dislike conventional rehabilitation methods.

The organization plans to use the December 2023 funding to develop new functions and games that will enable Jam Fun AR to reach more children. The company will use the June 2024 funding to further increase its user base, enhance its customer development, product technology including the improvement of AI models, and rehabilitation exercise contents to increase accessibility for children with disabilities and boost global awareness.

## Funding rounds

- Seed, Dec 29, 2023, $0.2M — Digital Healthcare Partners, Korea Investment Accelerator

## Investors

- Digital Healthcare Partners (https://capitalatlas.ai/funds/digital-healthcare-partners) — Seed
- Korea Investment Accelerator (https://capitalatlas.ai/funds/korea-investment-accelerator) — Seed